GoodRx Holdings GDRX
NASDAQ GDRX
$3.65 +0.14 (+3.99%)
At close: Nov 9, 2026 · 4:00 PM EST

GoodRx Holdings (GDRX) Gains from Sales and Divestitures (2022 - 2023)

Updated

GoodRx Holdings' Gains from Sales and Divestitures came in at -$360,000 for Q4 2023, compared with $11.4 million a year earlier.

Analysis

GoodRx Holdings (GDRX) Gains from Sales and Divestitures (2022 - 2023) Analysis & Trends

For FY2023, GoodRx Holdings' Gains from Sales and Divestitures was -$7.98 million.

  • Going back by year, Gains from Sales and Divestitures was $11.4 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Bryn 945.00 Bn 945.00 Bn -
2 Veeva Systems 49.70 Bn 21.94 Bn 695.95 Mn
3 Samsara 24.71 Bn 21.48 Bn 392.58 Mn
4 Ptc 22.46 Bn 21.27 Bn 490.47 Mn
5 Toast 20.17 Bn 12.81 Bn 543.00 Mn
6 Manhattan Associates 14.80 Bn 13.86 Bn 174.30 Mn
7 Bentley Systems 14.11 Bn 13.58 Bn 349.55 Mn
8 Trimble 12.72 Bn 11.80 Bn 659.10 Mn
9 Costar 12.56 Bn 7.94 Bn 741.00 Mn
10 GoodRx Holdings 1.23 Bn 166.10 Mn 179.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -360,000.00
Dec 31, 2022 11.40 Mn
API Access

GoodRx Holdings Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=GDRX&period=max&api_key=YOUR_API_KEY